Geuder discusses new products

Article

Geuder Group discussed several new products, including Brilliant Peel vitreoretinal fluid dye and Siluron 2000, during a posterior segment symposium at this year's Euretina meeting.

Geuder Group discussed several new products, including Brilliant Peel vitreoretinal fluid dye and Siluron 2000, during a posterior segment symposium at this year's Euretina meeting.

Brilliant Peel, developed by Fluoron GmbH in cooperation with renowned doctors from across Europe, is used to provide selective colouration of the inner limiting membrane (ILM) during posterior segment surgery. The non-toxic triphenylmethane dye, which is CE-marked, is available now.

Siluron 2000, a non-emulsifying long-term tamponade, has a reduced viscosity of 2000 mPas and is designed to be used during microincision surgery. The product will be launched later this year.

During the lunch symposium, speakers also discussed, among other topics, when 23 gauge or 25 gauge surgery should be undertaken and complications arising from the use of heavy liquids.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.